2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers Lain Anderson TJ Bilodeau Read more
Related Practice Life Sciences & Pharma In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations. 01052021090143
Special Report Healthcare Services Bridge the Gap: Unlocking Innovative Medical Device Access in India via Evidence-based… February 11, 2025
Video / Webinar Life Sciences & Pharma Contrasting China's Market Dynamics with Global Pharma Giants August 16, 2024
Video / Webinar Healthcare Services AI in Healthcare: Passive, Reactive, or Proactive? August 2, 2024